These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26898501)
21. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. Fang J; Lu J; Holmgren A J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598 [TBL] [Abstract][Full Text] [Related]
22. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent. Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352 [TBL] [Abstract][Full Text] [Related]
24. Thioredoxin Reductase Inhibition for Cancer Therapy. Gencheva R; Arnér ESJ Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246 [TBL] [Abstract][Full Text] [Related]
25. Investigation of the C-terminal redox center of high-Mr thioredoxin reductase by protein engineering and semisynthesis. Eckenroth BE; Lacey BM; Lothrop AP; Harris KM; Hondal RJ Biochemistry; 2007 Aug; 46(33):9472-83. PubMed ID: 17661444 [TBL] [Abstract][Full Text] [Related]
26. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling. Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363 [TBL] [Abstract][Full Text] [Related]
27. Identification and conformer analysis of a novel redox-active motif, Pro-Ala-Ser-Cys-Cys-Ser, in Drosophila thioredoxin reductase by semiempirical molecular orbital calculation. Kuwahara M; Tamura T; Kawamura K; Inagaki K Biosci Biotechnol Biochem; 2011; 75(3):516-21. PubMed ID: 21389620 [TBL] [Abstract][Full Text] [Related]
28. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis. Fritz-Wolf K; Urig S; Becker K J Mol Biol; 2007 Jun; 370(1):116-27. PubMed ID: 17512005 [TBL] [Abstract][Full Text] [Related]
29. Different catalytic mechanisms in mammalian selenocysteine- and cysteine-containing methionine-R-sulfoxide reductases. Kim HY; Gladyshev VN PLoS Biol; 2005 Dec; 3(12):e375. PubMed ID: 16262444 [TBL] [Abstract][Full Text] [Related]
30. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. Cenas N; Prast S; Nivinskas H; Sarlauskas J; Arnér ES J Biol Chem; 2006 Mar; 281(9):5593-603. PubMed ID: 16354662 [TBL] [Abstract][Full Text] [Related]
31. Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif. Shi W; Sun S; Liu H; Meng Y; Ren K; Wang G; Liu M; Wu J; Zhang Y; Huang H; Shi M; Xu W; Ma Q; Sun B; Xu J Redox Biol; 2024 Apr; 70():103050. PubMed ID: 38277963 [TBL] [Abstract][Full Text] [Related]
32. TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Cebula M; Schmidt EE; Arnér ES Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897 [TBL] [Abstract][Full Text] [Related]
33. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. Peng X; Xu J; Arnér ES Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015 [TBL] [Abstract][Full Text] [Related]
34. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1. Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724 [TBL] [Abstract][Full Text] [Related]
35. Selenium as an electron acceptor during the catalytic mechanism of thioredoxin reductase. Lothrop AP; Snider GW; Ruggles EL; Patel AS; Lees WJ; Hondal RJ Biochemistry; 2014 Feb; 53(4):654-63. PubMed ID: 24422500 [TBL] [Abstract][Full Text] [Related]
36. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. Peng X; Zhang MQ; Conserva F; Hosny G; Selivanova G; Bykov VJ; Arnér ES; Wiman KG Cell Death Dis; 2013 Oct; 4(10):e881. PubMed ID: 24157875 [TBL] [Abstract][Full Text] [Related]
37. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. Anestål K; Prast-Nielsen S; Cenas N; Arnér ES PLoS One; 2008 Apr; 3(4):e1846. PubMed ID: 18382651 [TBL] [Abstract][Full Text] [Related]
38. Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni. Huang HH; Day L; Cass CL; Ballou DP; Williams CH; Williams DL Biochemistry; 2011 Jul; 50(26):5870-82. PubMed ID: 21630672 [TBL] [Abstract][Full Text] [Related]
39. Gain of function conferred by selenocysteine: catalytic enhancement of one-electron transfer reactions by thioredoxin reductase. Barber DR; Hondal RJ Protein Sci; 2019 Jan; 28(1):79-89. PubMed ID: 30052295 [TBL] [Abstract][Full Text] [Related]
40. Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1. Kurokawa S; Eriksson S; Rose KL; Wu S; Motley AK; Hill S; Winfrey VP; McDonald WH; Capecchi MR; Atkins JF; Arnér ES; Hill KE; Burk RF Free Radic Biol Med; 2014 Apr; 69():67-76. PubMed ID: 24434121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]